Comparing quality of life after surgery for endometriosis with and without medication
Official title: The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
Run by Main Line Health · NCT06439524 · Data updated 2026-11-12
This study is testing if a new combination therapy after surgery for endometriosis can improve the quality of life for women who have had the surgery.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 110 (estimated) |
| Sponsor | Main Line Health Academic / other |
| Locations | 1 site (Wynnewood, Pennsylvania) |
| Status | Recruiting |
| Started | August 15, 2024 |
| Main results expected | June 30, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT06439524 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women over the age of 18 planning to undergo elective laparoscopic surgery for known or suspected endometriosis.
✕Probably not a fit
Patients with contraindications to Rel-CT or those interested in pregnancy within the next 12 months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the impact of Relugolix combination therapy (Rel-CT) on the quality of life of women who have undergone excisional surgery for endometriosis. Participants will be randomly assigned to receive either Rel-CT or no hormonal suppression after their surgery. The primary outcome will be measured using the Endometriosis Health Profile 30 (EHP-30) scores, which assess health-related quality of life. The study will involve women over the age of 18 who are scheduled for laparoscopic surgery for endometriosis, with careful screening and exclusion criteria to ensure participant safety.
Why it matters
Potential benefit: If successful, this study could improve the quality of life for women recovering from endometriosis surgery by demonstrating the benefits of immediate post-operative medication.
How similar studies have gone: Other studies have explored hormonal treatments for endometriosis, but this specific approach of immediate post-operative Rel-CT is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Age ≥ 18 years * Planning to undergo an elective laparoscopic or robotic procedure for known or suspected endometriosis Exclusion criteria -A known contraindication to REL-CT. Contraindications include: * High risk of arterial, venous thrombotic, or thromboembolic disorder * Pregnancy Known osteoporosis * Current or history of breast cancer or other hormone-sensitive malignancies * Known hepatic impairment or disease * Undiagnosed abnormal uterine bleeding * Known hypersensitivity to components of Rel-CT * The patient did not discontinue hormonal suppression within the required timeline: Trans-Dermal, Oral Medication, Patch, or Vaginal Ring: day before surgery Intrauterine Device or Sub-Dermal Implant: removed at surgery Injectable Medication: at least 12 weeks before surgery * Primary language other than English/Spanish * Interested in pregnancy within the 6 months following the surgical procedure. * If pregnancy test performed during pre-surgical work up is positive, the patient will no longer be a candidate for endometriosis surgery and will therefore not be eligible for the study. * Patients without histologic evidence of endometriosis following their surgical procedure will be removed from the study prior to receiving the study intervention. * Patients who undergo a surgical intervention more invasive than the planned laparoscopic or robotic excisional surgery, such as open abdominal surgical repair, will be removed from the study prior to receiving the study intervention.
Where it's running
-
Main Line Health
Wynnewood, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Jordan Klebanoff, MD — Main Line Health
- Study coordinator: Jordan Klebanoff, MD
- Email: Klebanoffj@mlhs.org
- Phone: 610-896-4380
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.